Repligen Corporation
NASDAQ: RGEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Olivier Loeillot
- Employees
- 1,778
- Headquarters
- Waltham, United States
- IPO year
- 1986
- Market cap
- $7.4B
- Website
- https://www.repligen.com
Loading RGEN…
Loading profile data…Frequently asked questions about RGEN
What does Repligen Corporation (RGEN) do?
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfoli...
Where does RGEN trade?
Repligen Corporation (RGEN) trades on the NASDAQ Global Select.
What sector is RGEN in?
Repligen Corporation (RGEN) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Repligen Corporation?
Olivier Loeillot is the chief executive officer of Repligen Corporation (RGEN).
Where is Repligen Corporation headquartered?
Repligen Corporation is headquartered in United States.
Does RGEN pay a dividend?
Repligen Corporation (RGEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RGEN go public?
Repligen Corporation (RGEN) completed its initial public offering in 1986.